Major Updates in Health: Drug Approvals, Legal Battles, and Health Innovations

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for Zevra's rare genetic disorder treatment, and the FTC's lawsuit against high insulin prices. Additionally, advances in MS treatment, mpox outbreak control, and fertility treatments are highlighted.

Recent health news highlights several significant advances and legal battles. The European Medicines Agency has endorsed Novo Nordisk's Wegovy for easing heart failure in obese individuals, signaling its broader health benefits. In the United States, the FDA has approved Zevra Therapeutics' treatment for a rare genetic disorder, a significant milestone after overcoming previous roadblocks.

The US Federal Trade Commission has launched a lawsuit against the country's largest pharmacy benefit managers, accusing them of manipulating insulin prices for financial gain. The case targets giants such as UnitedHealth Group's Optum, CVS Health's CVS Caremark, and Cigna's Express Scripts.

Additional updates include Sanofi's successful trial for a progressive multiple sclerosis drug, efforts to end the mpox outbreak in Burundi, and advancements in making older eggs suitable for in-vitro fertilization. The FDA's approval of AstraZeneca's self-administered nasal spray flu vaccine is also a notable innovation in preventive health care.

(With inputs from agencies.)